课题基金 / 基金详情

A Screening System for Development of Novel Insulin Secretagogues

A Screening System for Development of Novel Insulin Secretagogues
新型胰岛素促分泌剂开发的筛选系统
批准号:
09557075
负责人:
SEINO Susumu
金额:
$7.62万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

SEINO Susumu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Development of novel insulin secretagogues is important for the treatment of diabetes mellitus. Sulfonylureas are widely used in the treatment of type 2 diabetes. Sulfonylureas stimulate insulin secretion by inhibiting ATP-sensitive K^+ channels in pancreatic beta-cells. We have recently shown that the beta-cell K_<ATP> channel comprises the inward rectfier K^+ channel subunit Kir6.2 and the sulfonylurea receptor subunit SURI which shows high affinity for the sulfonylurea glibenclamide. We also cloned an isoform of SUR1, called SUR2A which shows low affinity for glibenclamide. To develop screening system of the effectiveness of novel sufonylureas and their derivatives, we have determined 1) the subunit stoichiometry of the beta-cell K_<ATP> channel, 2) sulfonylurea binding sites in the SUR1 ; and 3) we generated Kir6.2 deficient mice.1). By using fusion proteins of SUR1 and Kir6.2, we found that the activity of K_<ATP> channels is optimized when the the SUR1 subunit and the Kir6.2 subu … More nit are coexpressed with a molar ratio of 1 : 1. Since inward rectifier K^+ channels are thought to function as homo- or hetero-tetramers, this suggests that the beta-cell K_<ATP> channel functions as a hetero- octamer composed of four Kir6.2 subunits and four SUR1 subunits.2). Various chimeras between SUR1 and SUR2A were prepared. We examined ^3H labeled glibenclamide binding to COS-1 cells transfected with these chimeras and also the effect of glibenclamide on ^<36>Rb efflux from COS-1 cells transfected with each chimera and Kir6.2. We found that high affinity binding site for glibenclamide locates between 15 th and 16th transmembrane segement of SUR1.3). We generated K_<ATP> channel-deficient mice by genetic disruption of Kir6.2, which forms the K^+ ion-selective pore of the channel. The homozygous mice (Kir6.2^<-/->) lack K_<ATP> channel activity. No significant insulin secretion in response to either glucose or the sulfonylurea tolbutamide was found in K_<ATP> channel-deficient mice (Kir6.2^<-/->), as assessed by perifusion and batch incubation of pancreatic islets. Our studies should provide useful information for the development of new drugs for insulin secretion. Less
期刊论文(51)
专著(0)
科研奖励(0)
会议论文
Nestorowicz, A.et al.: "A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism." Diabetes. 46. 1743-1748 (1997)
Nestorowicz, A.等人:“内向整流钾通道基因 Kir6.2 中的无义突变与家族性高胰岛素血症有关。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yanase, H.et al.: "Cellular distribution of sulfonylurea receptor 2mRNA in the ovary and testis of rats." Biomed.Res.19. 199-204 (1998)
Yanase, H.et al.:“磺酰脲受体 2mRNA 在大鼠卵巢和睾丸中的细胞分布。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Miki, T.et al.: "The structure and function of the ATP-sensitive K^+ channel in pancreatic beta-cells." J.Mol.Endo.(in Press).
Miki, T.et al.:“胰腺 β 细胞中 ATP 敏感 K^ 通道的结构和功能。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mizuno,N.et al.: "Altered Bcl-2 and Bax expression and intracellular Ca^<2+> signaling in apoptosis of pancreatic β-cells and the impairment of glucose-induced insulin secretion." Endocrinology(in press). (1998)
Mizuno, N. 等人:“胰腺 β 细胞凋亡和葡萄糖诱导的胰岛素分泌受损中 Bcl-2 和 Bax 表达和细胞内 Ca^2+ 信号的改变(正在出版)。” )
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
34
    Elucidation of pancreatic beta-cell function by metabolomics and its clinical application
    • 批准号:
      24229007
    • 项目类别:
      Grant-in-Aid for Scientific Research (S)
    • 资助金额:
      $139.44万
    • 财政年份:
      2012
    • 负责人:
      SEINO Susumu
    • 依托单位:
    Mechanisms of functional expression of pancreatic islets as an integrated system and its failure
    • 批准号:
      21249057
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $29.37万
    • 财政年份:
      2009
    • 负责人:
      SEINO Susumu
    • 依托单位:
    Formation of the integrated insulin secretion system and its failure
    • 批准号:
      15002002
    • 项目类别:
      Grant-in-Aid for Specially Promoted Research
    • 资助金额:
      $380.22万
    • 财政年份:
      2003
    • 负责人:
      SEINO Susumu
    • 依托单位:
    Comprehensive Analysis of Genetic Factors in Diabetes Mellitus
    • 批准号:
      10NP0201
    • 项目类别:
      Grant-in-Aid for Creative Scientific Research
    • 资助金额:
      $208.0万
    • 财政年份:
      1998
    • 负责人:
      SEINO Susumu
    • 依托单位:
    国内基金
    海外基金
    同源异形盒基因HvVvl介导20E信号通路和insulin信号通路调控茄二十八星瓢虫变态发育的分子机制
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      潘慧鹏
    • 依托单位:
    基于稳态吸收和DPP-IV/GLP-1/Insulin通路解析牡蛎肽协同花色苷的降血糖增效机制
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      陈忠琴
    • 依托单位:
    Dif/FoxO激活miRNA调节Toll与insulin信号交互促进果蝇免疫代谢平衡的机制研究
    • 批准号:
      32370516
    • 项目类别:
      面上项目
    • 资助金额:
      51万元
    • 批准年份:
      2023
    • 负责人:
      马飞
    • 依托单位:
    基于多组学解析光环境促Insulin基因甲基化抑制PI3K/ACTBL2延缓近视发展的分子机制
    • 批准号:
      82301246
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2023
    • 负责人:
      黄煜
    • 依托单位: